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Mammals regulate fat mass so that increases or reductions in adipose tissue mass activate responses that
favor return to one’s previous weight. A reduction in fat mass activates a system that increases food intake
and reduces energy expenditure; conversely, overfeeding and rapid adipose tissue expansion reduces food
intake and increases energy expenditure. With the identification of leptin nearly two decades ago, the central
circuit that defends against reductions in body fat was revealed. However, the systems that defend against
rapid expansion of fat mass remain largely unknown. Here we review the physiology of the overfed state and
evidence for a distinct regulatory system, which unlike the leptin-mediated system, we propose primarily
measures a functional aspect of adipose tissue and not total mass per se.In recent decades, mean bodymass of populations in developed
countries has increased, with the largest proportional increases
occurring in individuals with the greatest weight (Flegal et al.,
2012). However, most individual adults—irrespective of level of
adiposity—maintain a relatively stable weight over long periods
of time gaining or losing only a couple of pounds in any given
year despite consumption of a million or more calories, suggest-
ing that bodymass is physiologically regulated (Passmore, 1971,
1982). At the beginning of the 20th century, Neumann (1902)
noted the remarkable stability of his own weight over more
than a year, despite no conscious effort to balance energy intake
with expenditure. He inferred that beyond short-term hunger and
satiety signals, humans defend body mass against large pertur-
bations, and he argued that the body compensates for excess
caloric intake by increasing energy expenditure in the form of
heat (a process that he termed luxusconsumption). Experimental
evidence for such a system began to emerge in the middle of the
20th century, with studies in both humans and rodents revealing
that perturbations in weight lead to metabolic responses, partic-
ularly feeding responses, that favor returning to a previous stable
weight.
The Physiology of the Weight-Reduced State
To successfully study the effects of weight perturbations in hu-
mans requires control of food intake and careful monitoring to
limit energy expenditure. Weight perturbation studies are chal-
lenging to perform because the responses alluded to above
tend to cause a return to previous weight. To ensure compliance,
especially with eating regimens, requires long-term monitoring,
typically housing subjects for months in clinical settings in which
metabolic measurements can be made. Keys, Brozek, and their
colleagues performed the first such studies, investigating the
metabolic adaptation of lean and healthy conscientious objec-
tors to World War II Keys et al. (1950). By limiting food intake
of study subjects until nearly all fat mass was lost, Keys et al.(1950) was able to measure the metabolic effects of reduced
fat mass. In this weight-reduced state, metabolic rate adjusted
for body surface area and physical activity were reduced, while
subjective measures of hunger were markedly increased. Keys
et al. (1950) established that in response to severely reduced
fat mass in lean individuals, metabolism and behavior are modi-
fied to favor weight gain and restoration of previous weight.
While the data were compelling, the extreme degree of weight/
fat loss and the subjects all being young, lean, healthy men
limited the broader applicability of their findings. The study did
not address whether more modest reductions in fat mass would
cause reductions in energy expenditure and increase hunger,
and it left open the question of whether obese and lean individ-
uals respond differently to weight loss.
To investigate the effects of more modest weight loss in both
obese as well as lean individuals, several inpatient studies were
performed beginning in the 1980s. The response to moderate
weight loss mirrored the effects seen by Keys et al. (1950), and
was surprisingly the same in obese and lean subjects (Leibel
and Hirsch, 1984; Leibel et al., 1995). In both obese and lean
individuals who maintained either a 10% or 20% reduced body
mass, energy expenditure and behavior were altered in ways
that favored restoration of previous weight (Rosenbaum et al.,
2003, 2008b). Weight reduction (see Figure 1) lowered energy
expenditure (EE) 15%–20% below what could be accounted
for by changes in body mass and composition, and increased
hunger. These changeswere also associatedwith reduced circu-
lating concentrations of thyroid hormones, reduced sympathetic
tone, and increased work (i.e., chemomechanical) efficiency of
skeletal muscle (Rosenbaum et al., 2005). These metabolic ad-
aptations do not subside over time, even if weight loss is main-
tained for years (Rosenbaum et al., 2008a), yet they are rapidly
reversed if weight is regained. A meta-analysis of data from
several weight loss studies also found that in formerly obese pa-
tients who successfully maintain a reduced body weight, there isCell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc. 565
Figure 1. Physiological Consequences of Changes from Body
Weight Set Point
Increases in body fat activate systems that favor a return to a lower fat mass.
Conversely, reductions in fat mass activate a leptin-dependent system that
favors a return to a higher fat mass.
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Because lower resting metabolic rate predicts future weight
gain (Ravussin et al., 1988), the metabolic response to weight
loss is one that strongly favorsweight regain. Aminority of clinical
studies have not detected a reduced energy expenditure associ-
ated with reduced fat mass, but the ability of these studies to
detect significant differences may have been compromised by
the sample size and by not housing patients on a clinical research
center for the duration of the studies (Amatruda et al., 1993; de
Peuter et al., 1992).
However, weight reduction of rodents by food restriction has
consistently revealed an adaptive response that favors restora-
tion of previous body fat similar to the human inpatient studies.
Diet-induced obese (i.e., fed a high-fat diet) and never-obese
(i.e., fed a low-fat diet) male mice that are weight reduced to
20% below their initial body mass by hypocaloric feeding have
significantly lower energy expenditure (adjusted for body mass
and body composition), increased food-seeking behavior, and
lower circulating thyroid hormone concentrations than never-
weight-reduced control animals (Ravussin et al., 2011). Not sur-
prisingly, these weight-reduced animals rapidly regain lost
weight once food deprivation is lifted (Ravussin et al., 2012).
However, they never overshoot; rather, they gain fat mass to
match the adiposity of ad libitum fed control animals (Levin
and Keesey, 1998; reviewed in Keesey and Hirvonen, 1997).
These observations suggest that a system exists that also regu-
lates the upper limit of fat mass.566 Cell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc.The Physiology of the Overfed/Weight-Augmented State
During the 1960s, in studies that in many ways were the recip-
rocal of the work of Keys et al. (1950), Sims et al. (1973) overfed
youngmale prisoners so that they gained andmaintained weight
(mean weight gain of 16.2 kg) for more than 10 weeks, a con-
dition they termed ‘‘experimental obesity.’’ In response to an
increase in body weight, appetite decreased and energy expen-
diture increased when compared to men of matched adiposity
who were not overfed and weight augmented (Sims et al.,
1973). As Sims et al. (1973) noted, this response favored the
loss of fat mass and the return to their original preobese body
weight. Although the magnitude of changes in energy expendi-
ture reported in the Sims et al. (1973) studies have been debated,
long-term inpatient studies confirmed that overfeeding and
weight gain increase energy expenditure and reduce food intake
in both lean and obese individuals (Leibel et al., 1995). In
response to a 10% gain in body mass through increasing
food intake, weight-stable lean and obese individuals increased
energy expenditure and reduced muscle work efficiency (Rose-
nbaum et al., 2003).
Directly mirroring the human response to overfeeding, ani-
mals become hypermetabolic following periods of caloric
excess. Overfeeding rodents through gastric feeding tubes
or daily gavage augments fat mass and leads to a graded
decrease in voluntary feeding (Cohn and Joseph, 1962) and
an increase in energy expenditure (Rothwell and Stock, 1979).
When overfeeding is stopped, animals eat fewer calories and
expend more energy than ad libitum fed controls until they
reach the weight of never-overfed animals (Cohn and Joseph,
1962). Thus, complementary responses to the weight-reduced
or -augmented state are consistent with the existence of
homeostatic mechanisms that favor stability of fat stores in
mammals.
Lipostatic Model of Weight Regulation
Hetherington and Ranson (1940) and subsequently Brobeck
(1957) ablated regions of the rat hypothalamus in functional
neuroanatomical mapping studies. The nominally discrete
lesions in the region of the ventral medial hypothalamus
(VMH) induced responses similar to those observed in the
subjects of Keys et al. (1950): increased food-seeking be-
havior, hyperphagia, and a reduction in metabolic rate. With
free access to food, the VMH-lesioned rats rapidly became
obese (Hetherington and Ranson, 1940). These animals
behaved as if they were starved. Within hours of lesioning,
animals were hyperphagic and quickly began to gain weight.
While there was variation in the degree of hyperphagia and
the rate of weight gain depending on the size and precise
location of the lesion, all of the VMH-lesioned animals became
obese and subsequently defended (in response to food re-
striction) higher body weights. Conversely, electrical stimula-
tion of the VMH inhibited food intake and induced weight
loss (Hoebel and Teitelbaum, 1962).
In contrast to VMH damage, lesions to the lateral hypothala-
mus (LH) caused aphagia; these lesioned rats required special
feeding protocols to keep them alive until spontaneous food
intake was restored (Brobeck, 1957). Conversely, stimulation
of this same region induced feeding behavior. Although there
was variation in the quantitative responses, the qualitative
Figure 2. Evidence for a Circulating
Catabolic Factor in Overfed Animals
Diabetes animals (Leprdb/db) that have a mutation
in the receptor for leptin and animals that have
lesions that ablate their ventromedial hypothala-
mus (VMH) are hyperphagic and hypometabolic
and rapidly become severely obese. Parabiosis of
Leprdb/db or VMH-lesioned animals to lean con-
trols reduces food intake and induces weight loss
of lean parabiotic partners, leading to starvation in
a significant number of animals. Overfeeding ani-
mals (either via gavage or gastric tube) increases
body weight of overfed animals and reduces
voluntary food intake. Parabiosis of these animals
with lean controls also decreases food intake and
body fat in ad libitum fed parabiots.
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correlated with lesion size (Anand and Brobeck, 1951).
These studies were interpreted to indicate that body weight is
regulated by processes in which the hypothalamus ‘‘senses’’
weight via a ‘‘satiety center’’ located in the VMH and maintains
feeding by an ‘‘appetite center’’ in the LH. The identity of the
signals sensed by the VMH remained a source of speculation
for several decades. Mayer (1953) proposed that the weight-
regulating signal was glucose or a glucose metabolite, while
Brobeck (1960) suggested that hypothalamic temperature, as
a reflection of metabolic rate, was the central mediator. Kennedy
(1953, 1966), however, formulated a lipostat model of weight
regulation in which he argued that an adipose tissue-derived
metabolite provided a measure of fat mass sensed by neurons
in the VMH and the LH. He postulated that VMH-lesioned
animals were insensitive to its effects (Kennedy, 1953). He later
suggested that such an adipocyte-derived signal might be
a hormone (Kennedy, 1966). Porte and Woods (1981) sub-
sequently proposed that fat mass was indeed sensed by the
VMH, but indirectly by circulating insulin concentrations that
provided a measure of adipose tissue mass not derived from
fat per se (Leibel, 1977).
Parabiosis experiments—in which animals are surgically joined
to each other, permitting exchange of circulating factors and cells
(approximately a 3%–5% exchange of blood per minute) —pro-
vided direct evidence for a circulating satiety signal. In a seminal
series of parabiosis studies in which rats with hypothalamic le-
sions were surgically joined to control animals, Hervey (1959)
demonstrated that the circulation of obese VMH-lesioned ani-
mals contained a strongly anorexic/catabolic circulating factor(s).
When parabiosed to VMH-lesioned animals, unlesioned rats in
these studies markedly reduced food intake and lost weight,
leading many to starve to death (Hervey, 1959) (see Figure 2).
Leptin as the Regulatory Signal of the
Weight-Reduced State
Working at the Jackson Laboratory, Coleman and Hummel
(1969) recognized the similarity between VMH-lesioned rats
and mice segregating for the autosomal recessive obese (ob)
or diabetes (db) alleles. He performed parabiosis experiments
with paired combinations of control lean and mutant obese
and diabetes animals. He found that the effect of diabetes ani-
mals on a control parabiont mirrored the effect of VMH-lesioned
rats, causing anorexia, weight loss, and in some instances death
from inanition (Figure 2). In contrast, the obese mice rapidly lostweight when parabiosed with either control or diabetes animals.
Coleman (1973) concluded that obese mice lacked a circulating
satiety factor and that diabetes mice lacked the ability to sense
this factor. He proposed that the obese mice harbored a muta-
tion in the factor or pathway required for its production and
that diabetes mice were genetically deficient in its receptor. In
the mid-nineties, the obese and diabetes mutations were map-
ped genetically, leading to the cloning of leptin (Lep) (Zhang
et al., 1994) and its receptor (Lepr) (Chen et al., 1996; Chua
et al., 1996; Lee et al., 1996).
Consistent with Coleman’s hypothesis, leptin (the protein
product of the obese gene) is an adipocyte-derived hormone
that circulates at concentrations proportional to fat mass in
weight-stable rodents and humans (Coleman, 1973; Leibel,
2008). Also in support of Coleman’s hypothesis, the leptin recep-
tor is highly expressed in the VMH (and elsewhere in the hypo-
thalamus) (Coleman, 1973). Physiologic experiments confirmed
a leptin-leptin receptor axis as providing a means for the periph-
ery to communicate the size of fat stores to the CNS. Circulating
concentrations of leptin decline rapidly in response to reduced
body fat and food intake, providing a dynamic measure of exist-
ing fat stores and acute changes in energy balance (Ahima et al.,
1996).
The relevance of the leptin axis to energy homeostasis in hu-
mans was quickly established. Montague et al. (1997) identified
several obese children who were homozygous for inactivating
mutations in leptin, and Cle´ment et al. (1998) described indi-
viduals with obesity due to leptin receptor mutations. Humans
homozygous for these mutations are extremely hyperphagic,
with a phenotype that closely parallels those of the obese and
diabetes mice.
Consistent with its role as a signal that mediates metabolic/
behavioral responses to the weight (fat)-reduced state, leptin
administration reverses many of these consequences of weight
loss. Leptin administration to calorically restricted rodents with
reduced circulating concentrations of leptin increases energy
expenditure to preweight loss or prefasted levels (Do¨ring et al.,
1998) and similarly reverses starvation-induced changes in
gonadal, adrenal, immune, and thyroid function (Ahima et al.,
1996; Korner et al., 2001). Similarly, in humans leptin reverses
metabolic and behavioral changes that result from diet-induced
reductions in fat mass; it increases energy expenditure, sympa-
thetic tone, and thyroid hormones while reducing hunger in
obese and lean subjects who maintain a reduced body weight
(Leibel et al., 1995; Rosenbaum et al., 2002, 2005, 2008b;Cell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc. 567
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phenotypes after weight loss, and its action on neurons central
in the defense against reduced fat mass, established leptin as
a key metabolic hormone in the defense against reduced fat
mass. A reduction in the circulating concentration of leptin acti-
vates—primarily through the CNS—the metabolic and behav-
ioral responses that favor weight regain (Ahima et al., 1996;
Rosenbaum et al., 2002, 2005). Much effort is now focused on
mapping the neuronal circuits responsible for leptin’s actions
(Myers and Olson, 2012; Vong et al., 2011).
Leptin Is Not the Regulatory Signal of the
Overfed/Weight-Augmented State
Kennedy (1953) originally imagined a single signal that would
protect against large alterations in fat stores, responding to
both caloric restriction and overfeeding. Leptin has proven to
be the critical signal of the weight-reduced state; as noted,
decreased circulating concentrations of leptin activate central
systems that increase feeding behavior and the efficiency of en-
ergy utilization (Kelesidis et al., 2010). However, despite initial
predictions (and the naming of the hormone for the Greek
word for ‘‘thin’’ or ‘‘fine’’: leptos), leptin does not appear to be
the signal that limits excess fat expansion.
In contrast to the ability of leptin to reverse many of the meta-
bolic and endocrine effects of relative (i.e., weight reduced,
fasted) or absolute leptin deficiency (i.e., genetic mutations) (Lei-
bel, 2002), increases in circulating leptin do not mimic the over-
fed response. When rodents or humans at usual or increased
weights are administered physiological doses of leptin, they
show minimal metabolic response (Mackintosh and Hirsch,
2001). Even supraphysiological doses of leptin (i.e., 10-fold ele-
vations of plasma leptin concentrations) caused only modest
weight loss (Heymsfield et al., 1999). Similarly, in rodents phar-
macological doses of leptin, which increase serum concentra-
tions 1,000-fold, causes a modest and temporary reduction in
food intake that is subject to rapid tachyphylaxis (Faouzi et al.,
2007). This is in contrast to the effects of the overfed/weight-
augmented state in which voluntary food intake is reduced and
energy expenditure increased. These observations also suggest
that the profound anorexia and weight loss seen in control ani-
mals parabiosed to either VMN-lesioned rats or diabetes mice
is not simply due to hyperleptinemia butmust require some other
factor or set of factors.
The relative lack of response to exogenous leptin and high
endogenous concentrations in obese individuals has been
termed leptin resistance (Myers et al., 2012). However, the meta-
bolic/behavioral responses to leptin repletion following weight
loss and/or fasting, even in obese individuals, suggest that lep-
tin’s major physiological role is related to signaling body fat
loss, rather than expansion. Furthermore, the apparent resis-
tance or lack of effect of high concentrations of leptin seen in
lean individuals (Heymsfield et al., 1999) indicates that obesity
per se does not cause resistance to leptin action (Myers et al.,
2012). An asymmetric model of leptin function has been
proposed in which decreased/low concentrations cause a
strong anabolic response, but increased/high concentrations
cause only a relatively small catabolic response (Leibel, 2002).
However, the fact that overfeeding leads to reduced food intake
and increased energy expenditure—in lean and obese rodents568 Cell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc.and humans—suggests that there is a regulatory system that
protects against rapid and excess fat expansion that is distinct
from leptin.
Characteristics of an Afferent Catabolic Signal that
Regulates the Overfed/Weight-Augmented Response
As outlined below, we infer from published data several charac-
teristics of this putative catabolic factor that limits weight gain
during periods of overfeeding. The molecule (1) is elevated in
the circulation of overfed animals, (2) requires intact leptin
signaling for its effects, (3) acts in both lean and obese individ-
uals, and (4) requires central integration and an intact ventral
medial hypothalamus. We further hypothesize that this catabolic
signal originates from adipose tissue and is proportional to a
functional aspect of the tissue. For simplification, we will refer
to a single afferent catabolic factor produced in the overfed,
weight-augmented state, but there may indeed be several fac-
tors that contribute to the metabolic effects of overfeeding.
The term ‘‘weight-augmented’’ refers to an increase in weight
that occurs through eating more than would voluntarily be eaten
(i.e., overfed/force fed). Thus, both lean and obese individuals
can be weight-augmented.
Catabolic Signal Circulates
Evidence that a circulating factor mediates the catabolic
response to overfeeding derives most compellingly from parabi-
osis experiments. In the 1980s, Nishizawa and Bray (1980) stud-
ied the effects of overfeeding in parabiosed rats. Consistent with
the presence of a catabolic circulating factor in overfed/force fed
animals, the parabiotic partner of overfed animals reduced food
intake and, after 2 weeks, weighed less and had reduced fat
mass compared to control parabiotic animals (Figure 2). Harris
and Martin (1984) confirmed the catabolic effect of parabiosing
an overfed rat with one fed ad libitum.
In overfed animals, once the over feeding is stopped and ani-
mals are given ad libitum access to food, they remain hypopha-
gic and even aphagic for up to several weeks, losing weight until
they reach the weight of never-overfed controls (Cohn and Jo-
seph, 1962). In contrast to the system that defends against
reduced fat mass in which a reduction of circulating leptin is
sensed and activates a central anabolic response, in overfed/
weight-augmented animals, parabiosis data suggest that in-
creases in the circulating concentrations of a catabolic factor
result in weight loss (Harris and Martin, 1984; Nishizawa and
Bray, 1980).
The Catabolic Signal Action Requires Leptin
If the same molecule(s) is responsible for anorexia observed in
parabiotic partners of VMN-lesioned, diabetes, and overfed an-
imals, then the catabolic molecule produced in the overfed state,
while distinct from leptin, also requires central leptin signaling;
i.e., the anorectic factor in the circulation of leptin receptor-defi-
cient diabetesmice does not lead to severe anorexia in diabetes
mice as it does in parabiotic partners of diabetesmice with intact
leptin signaling. Consistent with this hypothesis, overfed obese
Zucker rats (deficient in the leptin receptor) do not reduce caloric
intake or lose weight once permitted to eat ad libitum (Harris and
Martin, 1990). In contrast, similarly overfed control rats reduce
their caloric intake, losing weight until they reach a body mass
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whether elevated (in proportion to fat mass) leptin concentration
is required for the effects of a catabolic factor produced in the
weight-augmented state. Nonetheless, that low leptin signal
would predominate over any overfed signal makes evolutionary
sense; the consequences of insufficient fat stores—infertility
and potential starvation and death if food becomes scarce—
are generally more consequential than excess fat stores. Hence,
it is not surprising that a starvation signal—low [leptin]—predom-
inates over any anorexic signal from an overfed/weight-aug-
mented animal.
Catabolic Signal Regulates Metabolism in Lean
and Obese Individuals
Although intact leptin signaling is required for the overfed
response, obese individuals with intact leptin signaling do have
a catabolic response to overfeeding. Indeed, as discussed
above, the catabolic response of increased energy expenditure
and reduced food intake is comparable in overfed lean and
obese individuals (Leibel et al., 1995). Furthermore, overfeeding
rats until they become obese does not diminish the anorectic
response once they are permitted to eat ad libitum. These obser-
vations suggest that identifying the catabolic factor and its down-
stream targets could provide effective therapies for obesity.
The Parameters that Might Regulate Release
of a Catabolic Factor
Kennedy’s lipostatic model of body weight regulation predicts
that an afferent catabolic factor is produced in proportion to ad-
ipose tissue mass (Kennedy, 1953, 1966). One possibility is that
the catabolic factor is produced and released in a manner anal-
ogous to leptin. By mechanisms that remain obscure, adipo-
cytes measure their lipid content and release leptin in proportion
to triglyceride stores (Zhang et al., 2002). That system could be
used to similarly regulate the release of a catabolic factor.
Alternatively, the afferent catabolic factor may be released in
response to a functional aspect of adipose tissue that is indi-
rectly related to adipocyte volume/adipose tissue mass. Evolu-
tionarily, it makes sense that if adipocytes cannot accommodate
additional lipid, they should provide a signal to limit further food
intake and increase mobilization and oxidation of stored lipid.
The origin of this catabolic signal could again be derived from
adipocyte or indirectly from local adventitial cells or cells in distal
organs affected by the reduced efficiency of lipid storage in ad-
ipocytes.
Originally, Kennedy (1953) proposed that a metabolite of adi-
pose tissue that was altered by obesity might convey a signal
to the VMH. With hypertrophy, adipocytes become less efficient
at storing lipids and ultimately release fatty acids and glycerol.
Indeed bothmetabolites have been considered catabolic regula-
tory signals. Intravenous infusion of fatty acid lipid emulsions
suppresses food intake when administered with insulin in pri-
mates (Woods et al., 1984). Glycerol infusion into rats decreased
food intake (Glick, 1980), although attempts in humans revealed
no effect on food intake or weight loss (Leibel et al., 1980). How-
ever, the use of highly specific b3-adrenergic receptor agonists
that increase adipocyte lipolytic rates do not reduce body
mass in mice or humans (de Souza et al., 1997; Larsen et al.,
2002). Some have suggested that the lack of effect is due tocompensatorymechanisms blunting any anorexic effects. None-
theless, these data would seem to argue that the release of fatty
acids or glycerol alone is not sufficient to produce a catabolic
effect.
Beyond the adipocyte, the presence of increased/excessive
fat storage in an overfed state could be sensed locally by a non-
adipocyte population of cells. Indeed, immune cells do respond
to changes in lipid fluxes in adipose tissue (Kosteli et al., 2010; Xu
et al., 2013). A key function of immune cells is monitoring the
state of tissues for homeostatic perturbations. Expansion of ad-
ipose tissue in the setting of obesity activates a broad immune
response. Despite more than a decade of study, our understand-
ing of what regulates this response remains rudimentary. None-
theless, it is known that as fat mass increases and the efficiency
of storage of TG in adipocytes is reduced, lipids accumulate in
immune cells, especially a subset of CD11c+ adipose tissue
macrophages (Kosteli et al., 2010; Xu et al., 2013). We have hy-
pothesized that the immune response to expanding adipose tis-
sue mass is partly adaptive, serving to provide storage for local
excess lipids that cannot be accommodated by existing adipo-
cytes (Kosteli et al., 2010; Xu et al., 2013). If this hypothesis is
correct, then overwhelming this buffering function in overfed an-
imals could lead to the release of a catabolic signal that reduces
food intake and increases energy expenditure. This response
would ultimately restore the ability of the immune system to
adequately buffer lipids. Of course, activation of immune re-
sponses in other contexts (e.g., pathogen infections) reduces
food intake and increases energy expenditure, providing a pre-
cedent for immune regulation of energy expenditure and intake.
Finally, a stress signal derived from an organ distinct from ad-
ipose tissue could drive expression of a catabolic factor. While
excess lipids increase stress in adipocytes and local immune
cells within adipose tissue, such accumulation also increases
metabolic stress in other tissues. With a reduction in the adipose
tissue’s reserve capacity for lipid storage, neutral lipids and
metabolic byproducts accumulate inmuscle, liver, and beta cells
of the pancreas. Although the focus of analysis of such excess
lipids has been on local dysfunction, cellular stress responses
are activated. These signal systems, including atypical PKCs
and ER-stress pathways within nonadipose tissues, could regu-
late production and release of a catabolic factor (Samuel and
Shulman, 2012; Fu et al., 2012).
Central Sensing of the Overfed/Weight-Augmented
Response
Coordination of the behavioral andmetabolic responses to nutri-
tional status requires central integration. Leptin-regulated neu-
rons and pathways and populations of neurons activated by
weight reduction and caloric restriction have been intensively
studied. Virtually nothing is known about pathways activated
by overfeeding. Although many regions, including the VMH,
LH, arcuate, PVN, and VTA, have been implicated in anorectic ef-
fects, none, to our knowledge, are implicated in receiving a cata-
bolic factor of the overfed state.
Although the site(s) of action of a catabolic factor are not
known, it seems likely that it is sensed in a manner different
from that used for leptin sensing in response to reductions in fat
mass. Unlike leptin, which induces changes in behavior primarily
in response to the decline of circulating concentration below aCell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc. 569
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Figure 3. A Dual-Component Lipostatic Model
(A) Kennedy (1953, 1966) proposed a single satiety factor capable of inducing catabolic and anabolic effects in response to weight loss and gain, respectively.
(B) Leptin at reduced concentrations acts as a powerful anabolic factor regulating metabolic/behavioral responses to weight loss.
(C) We propose that a catabolic factor similarly regulates the response to overfeeding, augmented weight, and increased fat mass.
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fed state likely activates anorectic and hypermetabolic responses
in the CNS in continuous proportion to increases in its concentra-
tion. Parabiosis experiments suggest this directly. The severe
anorexia induced by parabiosis of rats to VMN-lesioned or leptin
receptor-deficient animals argues that the action of the weight-
augmented, overfed catabolic factor also requires intact VMH
(or at least fiber tracts that pass through this anatomical region;
Sclafani, 1971) (Figure 2). More recent and technologically so-
phisticated studies are describing the neuronal circuits that
directly integrate the various regions of the CNS that modulate
hunger (Krashes et al., 2014; Wu et al., 2009).
Genetic and Evolutionary Evidence for an Overfed/
Weight-Augmented Response
Have specific genetic variants been implicated in the develop-
ment of obesity or part of the overfed, weight-augmented
response? Without knowing the identity of components of this
system, it is not clear that any of the genes implicated either
by genome-wide association studies or studies of extreme phe-
notypes are involved in the response to overfeeding. What would
be the phenotype of an individual deficient in the response to the
overfed state? As we have imagined the system, such people
would not be unusually hungry or seek food but rather would
not limit their intake during periods of hypercaloric feeding.
Hence, unlike mutations that impair the leptin-regulated system,
genetic variants in the system that limit overfeeding may not be570 Cell Metabolism 20, October 7, 2014 ª2014 Elsevier Inc.apparent in the absence of a second alteration, either genetic or
environmental, that provides a stimulus to overeat.
While the evolutionary rationale for developing a system that
defends against too little fat seems clear—with insufficient fat
mass, an animal risks infertility, dying, or losing fetuses or suck-
ling offspring—the evolutionary pressure to evolve a system that
prevents excess adipose tissue mass is less apparent. Avoid-
ance of predation at upper extremes of adiposity—presumably
not readily achieved under most earlier environmental circum-
stances—would be one selective advantage. However, if, as
we imagine, the system works to limit expanding fat mass
when doing so becomes inefficient or ineffective, there would
be some evolutionary benefits; energy and efforts would be re-
directed to other evolutionarily beneficial behaviors (e.g., repro-
duction, caring for young) when ingesting more calories would
not provide additional survival advantage.
A Model for Defense against Deposition of Excessive
Fat Stores
We propose that the overfed/weight-augmented state activates
a local stress response in adipose tissue that triggers release of a
humoral catabolic factor. This catabolic signal is not leptin,
although intact leptin signaling is necessary for the action of
the catabolic factor. We propose that the catabolic factor reports
some aspect of adipocyte status that is related to the efficiency
with which more triglyceride can be added to adipocytes
(Figure 3). In our model, excess local triglycerides are partially
Cell Metabolism
Perspectivebuffered by immune cells. When this system’s buffering capacity
is exceeded, adipose tissue releases a circulating factor that
acts within the CNS to reduce food intake and increase energy
expenditure. The signal may be secreted directly by immune
cells or by other local cells in response to the stress response
of the immune cells. This model suggests that differences in
either the ability of adipocytes to store excess calories and/or
the function of adipose tissue immune cells to buffer excess
lipids can affect the upper limits of rates of weight gain and ab-
solute adiposity.
However, even if aspects of our model are incorrect, as surely
they are, identifying components of the system that limits fat
mass expansion in overfed animals will identify molecules and
pathways that might be deployed for the prevention and treat-
ment of obesity and its complications. A more detailed analysis
of the physiology of the overfed state and identifying factors
that circulate in high concentrations in leptin receptor-deficient
and VMN-lesioned animals provide rich opportunities to search
for endogenous catabolic factors.ACKNOWLEDGMENTS
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